CJC-1295 / Ipamorelin (No DAC) 20mg
Combination of CJC-1295 (No DAC), a GHRH receptor analog, and Ipamorelin, a selective ghrelin-receptor (GHS-R1a) secretagogue. Studied together for complementary stimulation of pulsatile GH release.
Research Focus:
Growth Hormone Research — CJC-1295 studied for GHRH-R activation and cAMP signaling.
Selective Secretagogue Research — Ipamorelin studied as a highly selective GHS-R1a agonist.
GH Release Pattern Research — Examined for pulsatile GH release without cortisol elevation.
Metabolic Signaling Research — Studied for downstream IGF-1 secretion dynamics.
Dual-Pathway Research — Investigated for complementary dual-pathway GH stimulation.
Pulse Pattern Research — Studied for GH pulse amplitude and frequency modeling.
RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
Not for human or veterinary use. Sold exclusively as a reference material for in-vitro and in-vivo laboratory research. Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.
+20mg){kind=link}